Market Cap

Immunovant, Inc. Market Capitalization:

$2.90 Billion

USD as of July 1, 2025

business Immunovant, Inc. Company Profile

Immunovant, Inc. Main Stock Listing

NASDAQ: IMVT

Market Capitalization History of Immunovant, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $309.91 B
Vertex Pharmaceuticals Incorporated $117.36 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $59.14 B
Marinomed Biotech AG $58.56 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Yearly evolution of Immunovant, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2025 $3.96 B -35.99%
Jan. 1, 2024 $6.19 B 157.56%
Jan. 1, 2023 $2.40 B 166.09%
Jan. 1, 2022 $903.0 M -82.09%
Jan. 1, 2021 $5.04 B 147.18%
Jan. 1, 2020 $2.04 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Immunovant, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Immunovant, Inc. has the following listings and related stock indices.


Stock: NASDAQ: IMVT

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.